BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6401839)

  • 1. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).
    Ratnoff OD; Menitove JE; Aster RH; Lederman MM
    N Engl J Med; 1983 Feb; 308(8):439-42. PubMed ID: 6401839
    [No Abstract]   [Full Text] [Related]  

  • 2. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired cell-mediated immunity in patients with classic hemophilia.
    Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
    N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic immune thrombocytopenic purpura in hemophilia A.
    Reen BS; Card RT; McSheffrey JB; Skinnider LF
    Can Med Assoc J; 1983 Nov; 129(9):990-1. PubMed ID: 6686949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some complications of the therapy of classic hemophilia.
    Ratnoff OD
    J Lab Clin Med; 1984 May; 103(5):653-9. PubMed ID: 6425440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-LAV/HTLV-III antibody positive hemophilia A accompanied with idiopathic (immunological) thrombocytopenic purpura--a case report].
    Okubo S; Kitajima H; Nagayama K; Yasunaga K
    Rinsho Ketsueki; 1987 Mar; 28(3):441-5. PubMed ID: 2441088
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
    Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
    Lederman MM; Ratnoff OD; Schacter B; Shoger T
    J Lab Clin Med; 1985 Aug; 106(2):197-204. PubMed ID: 2410523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemolytic anemia caused by infusion of factor VIII concentrates--a case report of hemophilia A with intracranial hemorrhage].
    Fukazawa K; Okuyama T; Manabe H; Kanaya J
    Rinsho Ketsueki; 1983 Jul; 24(7):892-6. PubMed ID: 6415317
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia.
    Karpatkin S; Nardi MA
    J Lab Clin Med; 1988 Apr; 111(4):441-8. PubMed ID: 3258345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed protocol for the evaluation of the effect of high purity factor concentrates on the immune system of hemophilia patients.
    Brettler DB
    Thromb Haemost; 1989 Sep; 62(2):811-2. PubMed ID: 2510353
    [No Abstract]   [Full Text] [Related]  

  • 15. Coexistent hemophilia A and idiopathic thrombocytopenic purpura.
    Hruby MA
    J Pediatr; 1977 May; 90(5):773-5. PubMed ID: 558299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immune disorders in hemophiliac patients].
    KachorovskiÄ­ BV; LoginskiÄ­ VE; Vygovskaia IaI; Rudenko VP
    Ter Arkh; 1987; 59(10):81-5. PubMed ID: 3124282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of AIDS-related complex with hemophilia A associated with idiopathic thrombocytopenic purpura].
    Koyama T; Sakiyama N; Kunitomi O; Wakabayashi K; Nishida K
    Rinsho Ketsueki; 1987 Oct; 28(10):1868-71. PubMed ID: 3483026
    [No Abstract]   [Full Text] [Related]  

  • 18. Lyophilized cryoprecipitate for children with hemophilia A.
    Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic thrombocytopenic purpura.
    Zwaan FE; De Koning J; Eernisse JG
    Neth J Med; 1974; 17(3):140-52. PubMed ID: 4367821
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic autoimmune thrombocytopenic purpura associated with haemophilia A.
    Mulholland MW; Edson JR; Delaney JP
    Postgrad Med J; 1982 Dec; 58(686):790-1. PubMed ID: 6892061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.